CLPT
ClearPoint Neuro, Inc.
$13.38
+3.80%
$401.3M
No data for this timeframe.
Vol
Market Cap$401.3M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (89%)
Inst. Holders8 funds
Inst. Value$32.6M
Inst. Activity2 buys / 2 sells
Insider Activity0B / 2S
Insider Net $-$122.6K
SEC Reports3
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001285550·Prev Close $12.89
Recent Activity
Jun 4, 2026
Insider
Richards Timothy T. sold 500 shares
Director @ $10.00 ($5.0K)
Jun 4, 2026
Insider
Richards Timothy T. sold 376 shares
Director @ $13.30 ($5.0K)
Jun 4, 2026
Insider
Richards Timothy T. sold 500 shares
Director @ $10.00 ($5.0K)
May 29, 2026
short_volume
Short Volume: CLPT — 57.7% short (0.4M / 0.6M)
Short: 352,324 | Exempt: 9,526 | TRF Vol: 610,893 | Short Ratio: 57.7% | Off-exchange volume (dark p
May 21, 2026
SEC
ClearPoint Neuro held its 2026 annual meeting on May 20, 2026. Stockholders approved the Seventh Amended and Restated 20
8-K — Impact 3/10
May 20, 2026
SEC
Director Lynnette C. Fallon filed a Form 144 to sell 5,091 shares of ClearPoint Neuro common stock, valued at approximat
144 — Impact 2/10
May 13, 2026
SEC
ClearPoint Neuro reported Q1 2026 revenue of $12.1M (+43% YoY), beating pre-release consensus? (no explicit consensus bu
8-K — Impact 5/10
Inst.
TWO SIGMA INVESTMENTS, LP — TRIM
219,221 shares ($3.0M)
Price Targets
$22.00
+61.9% upside
Strong Buy
Current $13.59
Low $16.00
Median $20.00
High $30.00
3 analysts
$16.00
$30.00
Analyst Ratings
3Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 18, 2026 | B. Riley Securities | MAINTAIN | Buy → Buy |
| Mar 5, 2026 | B. Riley Securities | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.29 ▼ -13.2% | $-0.33 — $-0.25 | -37% YoY | 3 |
| Next Q | $-0.26 ▼ -11.3% | $-0.31 — $-0.23 | -25% YoY | 3 |
| Current FY | $-1.11 ▼ -13.6% | $-1.24 — $-1.01 | -24% YoY | 3 |
| Next FY | $-0.94 ▼ -6.0% | $-1.08 — $-0.68 | 16% YoY | 3 |
Latest Reports
NEUTRAL
8-K
3/10
ClearPoint Neuro held its 2026 annual meeting on May 20, 2026. Stockholders approved the Seventh Amended and Restated 20
May 21, 2026
NEUTRAL
144
2/10
Director Lynnette C. Fallon filed a Form 144 to sell 5,091 shares of ClearPoint Neuro common stock, valued at approximat
May 20, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $24.2M | — |
| TWO SIGMA INVESTMENTS, LP | $3.0M | TRIM |
| RENAISSANCE TECHNOLOGIES LLC | $1.6M | NEW |
| MORGAN STANLEY | $1.5M | TRIM |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $1.1M | DOUBLED |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 4, 2026 | Richards Timothy | M | $5.0K |
| Jun 4, 2026 | Richards Timothy | F | $5.0K |
| Jun 4, 2026 | Richards Timothy | M | $5.0K |
| Jun 1, 2026 | Richards Timothy | SELL | $65.9K |
| May 21, 2026 | FALLON LYNNETTE | A | $0.00 |
8 institutional holders with $32.6M total value (2,383,313 shares) as of 2025-Q4. Top holders: VANGUARD, TWO, RENAISSANCE.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 1,766,677 | $24.2M | 74.1% | — |
| 2 | TWO SIGMA INVESTMENTS, LP | 219,221 | $3.0M | 9.2% | TRIM -29.4% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 120,000 | $1.6M | 5.0% | NEW |
| 4 | MORGAN STANLEY | 112,646 | $1.5M | 4.7% | TRIM -52.1% |
| 5 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 78,909 | $1.1M | 3.3% | DOUBLED +661.0% |
| 6 | BANK OF AMERICA CORP /DE/ | 48,085 | $657.8K | 2.0% | TRIM -62.1% |
| 7 | WELLS FARGO & COMPANY/MN | 29,856 | $408.4K | 1.3% | ADD +83.9% |
| 8 | FMR LLC | 7,919 | $108.3K | 0.3% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | TRIM | 310,526 | 219,221 | -29.4% | $3.0M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 120,000 | — | $1.6M | 2025-Q4 |
| MORGAN STANLEY | TRIM | 235,281 | 112,646 | -52.1% | $1.5M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 16,236 | 29,856 | +83.9% | $408.4K | 2025-Q4 |
| UBS Group AG | DOUBLED | 155,410 | 360,705 | +132.1% | $7.9M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 21,928 | 310,526 | +1316.1% | $6.8M | 2025-Q3 |
| MORGAN STANLEY | TRIM | 332,323 | 235,281 | -29.2% | $5.1M | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 113,698 | 43,127 | -62.1% | $939.7K | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 43,900 | 0 | -100.0% | $0.00 | 2025-Q3 |
| MORGAN STANLEY | DOUBLED | 157,970 | 332,323 | +110.4% | $4.0M | 2025-Q2 |
| UBS Group AG | ADD | 95,277 | 155,410 | +63.1% | $1.9M | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 27,394 | 113,698 | +315.0% | $1.4M | 2025-Q2 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | DOUBLED | 10,369 | 78,909 | +661.0% | $942.2K | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 21,928 | — | $261.8K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 69 | 13,532 | +19511.6% | $161.6K | 2025-Q2 |
| MORGAN STANLEY | ADD | 84,339 | 157,970 | +87.3% | $1.9M | 2025-Q1 |
| UBS Group AG | DOUBLED | 46,181 | 95,277 | +106.3% | $1.1M | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 51,000 | — | $606.4K | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 10,314 | 0 | -100.0% | $0.00 | 2025-Q1 |
| MORGAN STANLEY | ADD | 46,827 | 84,339 | +80.1% | $1.3M | 2024-Q4 |
| UBS Group AG | ADD | 30,968 | 46,181 | +49.1% | $710.3K | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 48,900 | 0 | -100.0% | $0.00 | 2024-Q4 |
| MORGAN STANLEY | TRIM | 90,199 | 46,827 | -48.1% | $524.9K | 2024-Q3 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 10,369 | — | $116.2K | 2024-Q3 |
11 unique insiders with 2 transactions. Net insider value: -$122.6K ($0.00 bought, $122.6K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Richards Timothy T. | Director | M | 500 | $10.00 | $5.0K |
| Jun 4, 2026 | Richards Timothy T. | Director | F | 376 | $13.30 | $5.0K |
| Jun 4, 2026 | Richards Timothy T. | Director | M | 500 | $10.00 | $5.0K |
| Jun 1, 2026 | Richards Timothy T. | Director | SELL | 5,415 | $12.17 | $65.9K |
| May 21, 2026 | FALLON LYNNETTE C | Director | A | 12,820 | $0.00 | $0.00 |
| May 20, 2026 | FALLON LYNNETTE C | Director | SELL | 5,091 | $11.14 | $56.7K |
| May 19, 2026 | Girin Pascal E R | Director | M | 12,417 | $0.00 | $0.00 |
| May 19, 2026 | Klein Matthew B. | Director | M | 12,417 | $0.00 | $0.00 |
| May 19, 2026 | Girin Pascal E R | Director | M | 12,417 | $0.00 | $0.00 |
| May 19, 2026 | JOHNSON B KRISTINE | Director | M | 12,417 | $0.00 | $0.00 |
| May 19, 2026 | LIAU LINDA M. | Director | M | 12,417 | $0.00 | $0.00 |
| May 19, 2026 | LIAU LINDA M. | Director | M | 12,417 | $0.00 | $0.00 |
| May 19, 2026 | FLETCHER R JOHN | Director | M | 12,417 | $0.00 | $0.00 |
| May 19, 2026 | FALLON LYNNETTE C | Director | M | 12,417 | $0.00 | $0.00 |
| May 19, 2026 | FLETCHER R JOHN | Director | M | 12,417 | $0.00 | $0.00 |
| May 19, 2026 | Richards Timothy T. | Director | M | 12,417 | $0.00 | $0.00 |
| May 19, 2026 | JOHNSON B KRISTINE | Director | M | 12,417 | $0.00 | $0.00 |
| May 19, 2026 | Richards Timothy T. | Director | M | 12,417 | $0.00 | $0.00 |
| May 19, 2026 | Klein Matthew B. | Director | M | 12,417 | $0.00 | $0.00 |
| May 19, 2026 | FALLON LYNNETTE C | Director | M | 12,417 | $0.00 | $0.00 |
| Apr 1, 2026 | Girin Pascal E R | Director | A | 755 | $9.10 | $6.9K |
| Apr 1, 2026 | FLETCHER R JOHN | Director | A | 1,270 | $9.10 | $11.6K |
| Apr 1, 2026 | Richards Timothy T. | Director | A | 442 | $9.10 | $4.0K |
| Mar 19, 2026 | BURNETT JOSEPH | CEO and President | M | 20,942 | $3.24 | $67.9K |
| Mar 19, 2026 | BURNETT JOSEPH | CEO and President | M | 20,942 | $0.00 | $0.00 |
| Mar 12, 2026 | D'Alessandro Danilo | Chief Financial Officer | M | 32,627 | $0.00 | $0.00 |
| Mar 12, 2026 | STIGALL L. JEREMY | Chief Business Officer | M | 30,995 | $0.00 | $0.00 |
| Mar 12, 2026 | SABRA MAZIN | Chief Operating Officer | M | 26,101 | $0.00 | $0.00 |
| Mar 12, 2026 | SABRA MAZIN | Chief Operating Officer | M | 26,101 | $0.00 | $0.00 |
| Mar 12, 2026 | SABRA MAZIN | Chief Operating Officer | F | 13,281 | $11.53 | $153.1K |
| Mar 12, 2026 | BURNETT JOSEPH | CEO and President | F | 43,161 | $11.53 | $497.6K |
| Mar 12, 2026 | D'Alessandro Danilo | Chief Financial Officer | F | 16,601 | $11.53 | $191.4K |
| Mar 12, 2026 | D'Alessandro Danilo | Chief Financial Officer | M | 32,627 | $0.00 | $0.00 |
| Mar 12, 2026 | BURNETT JOSEPH | CEO and President | M | 84,829 | $0.00 | $0.00 |
| Mar 12, 2026 | BURNETT JOSEPH | CEO and President | M | 84,829 | $0.00 | $0.00 |
| Mar 12, 2026 | STIGALL L. JEREMY | Chief Business Officer | M | 30,995 | $0.00 | $0.00 |
| Mar 12, 2026 | STIGALL L. JEREMY | Chief Business Officer | F | 15,151 | $11.53 | $174.7K |
| Mar 11, 2026 | STIGALL L. JEREMY | Chief Business Officer | M | 8,291 | $0.00 | $0.00 |
| Mar 11, 2026 | D'Alessandro Danilo | Chief Financial Officer | M | 4,145 | $0.00 | $0.00 |
| Mar 11, 2026 | STIGALL L. JEREMY | Chief Business Officer | M | 8,291 | $0.00 | $0.00 |
| Mar 11, 2026 | D'Alessandro Danilo | Chief Financial Officer | F | 2,109 | $11.62 | $24.5K |
| Mar 11, 2026 | STIGALL L. JEREMY | Chief Business Officer | F | 3,224 | $11.62 | $37.5K |
| Mar 11, 2026 | D'Alessandro Danilo | Chief Financial Officer | M | 4,145 | $0.00 | $0.00 |
| Mar 6, 2026 | BURNETT JOSEPH | CEO and President | M | 47,407 | $0.00 | $0.00 |
| Mar 6, 2026 | BURNETT JOSEPH | CEO and President | F | 22,709 | $10.00 | $227.1K |
| Mar 6, 2026 | BURNETT JOSEPH | CEO and President | M | 47,407 | $0.00 | $0.00 |
| Mar 6, 2026 | STIGALL L. JEREMY | Chief Business Officer | M | 17,778 | $0.00 | $0.00 |
| Mar 6, 2026 | STIGALL L. JEREMY | Chief Business Officer | F | 6,913 | $10.00 | $69.1K |
| Mar 6, 2026 | STIGALL L. JEREMY | Chief Business Officer | M | 17,778 | $0.00 | $0.00 |
| Mar 6, 2026 | SABRA MAZIN | Chief Operating Officer | M | 13,827 | $0.00 | $0.00 |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 2 neutral. Avg impact: 3.3/10.
NEUTRAL
8-K
3/10
ClearPoint Neuro held its 2026 annual meeting on May 20, 2026. Stockholders approved the Seventh Ame
May 21, 2026
NEUTRAL
144
2/10
Director Lynnette C. Fallon filed a Form 144 to sell 5,091 shares of ClearPoint Neuro common stock,
May 20, 2026
MIXED
8-K
5/10
ClearPoint Neuro reported Q1 2026 revenue of $12.1M (+43% YoY), beating pre-release consensus? (no e
May 13, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (89% buy). Based on 9 analysts: 3 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$22.00 mean target
+61.9% upside
Strong Buy (1.00)
$16.00 Low
$30.00 High
| Metric | Value |
|---|---|
| Current Price | $13.59 |
| Target Low | $16.00 |
| Target Mean | $22.00 |
| Target Median | $20.00 |
| Target High | $30.00 |
| # Analysts | 3 |
| Recommendation | Strong Buy (1.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.29 | $-0.33 | $-0.25 | -36.5% | -13.2% | 0↑ 1↓ | $0.0B | 38.2% | 3 |
| Next Q 2026-09-30 |
$-0.26 | $-0.31 | $-0.23 | -25.4% | -11.3% | 1↑ 1↓ | $0.0B | 53.9% | 3 |
| Current FY 2026-12-31 |
$-1.11 | $-1.24 | $-1.01 | -23.7% | -13.6% | 0↑ 2↓ | $0.1B | 43.7% | 3 |
| Next FY 2027-12-31 |
$-0.94 | $-1.08 | $-0.68 | 15.6% | -6.0% | 1↑ 1↓ | $0.1B | 20.4% | 3 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.287 | |
| 7d ago | $-0.287 | |
| 30d ago | $-0.253 | -0.033 |
| 60d ago | $-0.255 | -0.032 |
| 90d ago | $-0.210 | -0.077 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 18, 2026 | B. Riley Securities | MAINTAIN | Buy | Buy |
| Mar 5, 2026 | B. Riley Securities | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 5 | 1 | 0 | 0 | 89% | |
| May 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Apr 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Mar 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Feb 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Jan 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 29, 2026
short_volume
Short Volume: CLPT — 57.7% short (0.4M / 0.6M)
Short: 352,324 | Exempt: 9,526 | TRF Vol: 610,893 | Short Ratio: 57.7% | Off-exchange volume (dark pool + OTC)
May 13, 2026
earnings_calendar
CLPT Q1 2026 Earnings Scheduled — 2026-05-13
May 8, 2026
short_volume
Short Volume: CLPT — 67.3% short (0.4M / 0.6M)
Short: 397,669 | Exempt: 808 | TRF Vol: 590,510 | Short Ratio: 67.3% | Off-exchange volume (dark pool + OTC)
Mar 17, 2026
earnings_calendar
CLPT Q4 2025 Earnings After Market Close — 2026-03-17
Mar 10, 2026
short_interest
FTD: CLPT — 49,872 shares ($0.6M) failed to deliver
Settlement: 20260310, Price: $11.54, FTD Value: $575,522.88, CLEARPOINT NEURO INC COM STK (
Mar 4, 2026
short_interest
FTD: CLPT — 103,090 shares ($0.9M) failed to deliver
Settlement: 20260304, Price: $8.84, FTD Value: $911,315.6, CLEARPOINT NEURO INC COM STK (
Mar 4, 2026
earnings_calendar
CLPT Q4 2025 Earnings After Market Close — 2026-03-04
Mar 3, 2026
short_interest
FTD: CLPT — 114,677 shares ($1.1M) failed to deliver
Settlement: 20260303, Price: $9.80, FTD Value: $1,123,834.6, CLEARPOINT NEURO INC COM STK (
Mar 2, 2026
earnings_calendar
CLPT Q4 2025 Earnings After Market Close — 2026-03-02